Bristol Myers Squibb· @bmsnews · X·· 26 天前AI 评分8
AI 导读
很高兴分享,我们的在研抗癌资产近期在第13届年度ADC Awards上荣获"最佳ADC临床影响力"奖。这一认可令人鼓舞,尤其是我们即将在#ESMO26上展示该ADC资产的数据:https://bit.ly/4i92P0d
正文
Pleased to share our investigational cancer asset was recently awarded Best ADC Clinical Impact during the 13th Annual ADC Awards. This recognition is encouraging, particularly as we approach #ESMO26 where we’ll be presenting data on our ADC asset: https://bit.ly/4i92P0d
来源:Bristol Myers Squibb · x.com